Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1381 of 6351
-
Could a common probiotic keep precancerous colon polyps away?
Prevention Recruiting nowThe prevention of recurrence after colorectal adenoma resection remains an urgent medical issue to be addressed. Previous studies have mainly focused on nonsteroidal anti-inflammatory drugs, calcium supplements, and vitamins. The gut microbiota and its metabolic products are beli…
Phase 4 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo targets genetic fatty liver in Mid-Stage trial
Disease control Recruiting nowThis study will test a study drug called ALN-PNP with and without another drug that is used for controlling blood sugar, appetite, and weight (for example, tirzepatide), to see if it can help treat MASLD, also known as fatty liver disease. ALN-PNP reduces the amount of Patatin-li…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could ecstasy help treat bulimia? early trial begins
Disease control Recruiting nowThis project will evaluate MDMA Assisted Therapy (MDMA-AT) assisted psychotherapy for the treatment of Bulimia Nervosa (BN) over a 10-week period. Preliminary data suggests that MDMA can facilitate heightened openness and reduce anxiety. This study will determine whether MDMA-ass…
Phase 1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Massive study aims to crack the code of KRAS-Mutant pancreatic cancer
Knowledge-focused Recruiting nowConstruction and Maintenance of a Precision Subtyping-Based Clinical Cohort for Targeted Therapy in KRAS-Mutant Pancreatic Cancer
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can an online program help teens stop Self-Injury?
Symptom relief Recruiting nowThe overall purpose of the study is to implement and evaluate IERITA (Internet-delivered Emotion Regulation Individual Therapy for Adolescents) within child and adolescent mental health services for adolescents engaging in nonsuicidal self-injury (NSSI) and optimize treatment out…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
No-Stitch eye gel could heal corneal wounds faster
Disease control Not yet recruitingCorneal blindness is one of the leading causes of blindness worldwide. For various infectious and non-infectious corneal diseases, current clinical repair strategies include corneal lesion debridement, conjunctival flap coverage, amniotic membrane transplantation, corneal transpl…
Sponsor: Suxia Li • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a common supplement fight chemo brain? new trial aims to find out
Symptom relief Recruiting nowThis is a phase I, dose-escalation and phase II dose-expansion clinical trial determining the maximum tolerated dose (MTD) and safety and tolerability of adding N-Acetyl-Cysteine (NAC) to ovarian cancer patients who are receiving a platinum-based therapy (PBT). This study will in…
Phase 1/2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could a blood spin help you get pregnant? new trial tests PRP in IUI
Disease control Not yet recruitingThe investigators hypothesize that infertility patients undergoing IUI who receive female autologous platelet-rich plasma (PRP) co-incubation with husband's sperm would have higher clinical pregnancy rate. Primary outcome: To compare the incidence of clinical pregnancy outcome …
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for kids with rare seizure disorder: ION337 trial launches
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).
Phase 1/2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a tiny ear tube offer lasting relief for middle ear infections?
Disease control Recruiting nowThe purpose of this project is to collect information from the doctor notes about the use of the device, to monitor the tubes after surgery, and collect information from patients and parents/guardians about their views on the procedure. Since the device became available in Europe…
Sponsor: AventaMed DAC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
AI eye on the colon: new trial tests smart detection for sneaky polyps
Diagnosis Recruiting nowThe aim of this study is to is to evaluate if a real-time Computer Aided Detection (CADe) system can help improve the detection of SSL(sessile serrated lesions) versus a conventional colonoscopy (CC) using white light examination(WLE).
Sponsor: National Healthcare Group, Singapore • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to tame rare kidney diseases
Disease control Recruiting nowThis is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults with complement-mediated kidney diseases. The study will enroll Chinese adults with IgA nephropathy, complement 3 glomerulopathy (C3G) and immune complex membra…
Phase 2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug could slow kidney disease in 182 patients
Disease control Not yet recruitingThe purpose of the study was to evaluate the efficacy and safety of HS-10390 in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) ≥ 30 and \<90 mL/min/1.73 m\^2, and urinary albumin to creatinine ratio (UACR) ≥ 150 mg/g and \< 3000 mg…
Phase 2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThe main purpose of the study is to evaluate the safety, tolerability and recommended dose of PM54 in combination with pembrolizumab. To assess the antitumor activity of PM54 in combination with pembrolizumab in terms of clinical benefit rate (CBR) and objective response rate (OR…
Phase 1/2 • Sponsor: PharmaMar • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
Disease control Not yet recruitingThe Azithromycin to Modify Bronchiectasis Exacerbation Risk (AMBER) trial is a prospective, randomized, double-blind, placebo-controlled, parallel-group clinical trial in adults with clinically and radiologically confirmed non-cystic fibrosis bronchiectasis (NCFB). The trial eva…
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Exercise may stop joint pain in breast cancer patients on hormone pills
Symptom relief Recruiting nowAromatase inhibitors (AI) are the standard adjuvant hormone therapy for postmenopausal women with hormone-sensitive breast cancer. However, nearly half of patients experience AI-induced musculoskeletal symptoms (AIMSS), particularly pain, which compromise quality of life and trea…
Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New drug aims to boost brain energy in Parkinson's patients
Disease control Recruiting nowThe main goal of the study is to investigate how well the new drug SUL-238 works in Parkinson's Disease (PD). This is done by means of an MRS scan. An MRS scan is similar to a regular MRI scan. It will also learn about the safety of new drug SUL-238. The main questions it aims to…
Phase 2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug rebecsinib enters human testing for tough blood cancers
Disease control Recruiting nowThe purpose of this study is to test the safest and most effective dose of a new investigational drug, rebecsinib. Participants in this study will have either Secondary Acute Myeloid Leukemia (sAML) that has either returned (relapsed) or not responded to treatment (refractory) or…
Phase 1 • Sponsor: Aspera Biomedicines, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Ambulance crews to launch opioid addiction treatment in the field
Symptom relief Recruiting nowThis is a multisite EMS study that will first conduct a sequence of pragmatic, prehospital field studies to provide preliminary feasibility, acceptability, and safety data for refinement and enhancement of a subsequent single-arm prospective trial that will provide preliminary ef…
Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Could a simple arm cuff replace bloodletting for high altitude disease?
Disease control Not yet recruitingThis study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The participants are adult patients with high-altitude polycythemia who have been long-term residents (for \>6 months) in regions at an altitude of ≥2500 meters. Participants are…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC